Kathleen A. Rickard holds the role of Chief Medical Officer at Verona Pharma plc (VRNA). Rickard has reported 6 insider filings with the SEC since 2024. The most recent filing was in October 2025.
Every role Kathleen A. Rickard has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
Verona Pharma plc (VRNA)6 filingsUpdated Aug 30, 2026
Kathleen A. Rickard is Chief Medical Officer of Verona Pharma plc (VRNA). 6 SEC Form 4 filings on record going back to 2024, most recently on 7 October 2025. Most recent open-market trade: sold $767K of VRNA on 1 August 2025. Lifetime open-market sales: $1.94M.
Every recent SEC Form 4 transaction Kathleen A. Rickard has reported, most recent first.
InsiderAlpha's records for Kathleen A. Rickard go back to 2024: 6 primary Form 4 filings, an average of 2.0 per year. 1 recorded transaction carries a Rule 10b5-1 flag, meaning it was pre-scheduled under a written trading plan rather than discretionary.
Insiders who have reported open-market trades at the same companies as Kathleen A. Rickard. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Kathleen A. Rickard is a corporate insider, tracked as Chief Medical Officer of Verona Pharma plc (VRNA). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
The most recent primary Form 4 on record is dated 7 October 2025, one of 6 filings going back to 2024.
Recorded transactions: 0 open-market purchases and 2 open-market sales ($1.94M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
$VRNA Verona Pharma plc2.43M shares @ --